JP2013508289A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013508289A5 JP2013508289A5 JP2012534359A JP2012534359A JP2013508289A5 JP 2013508289 A5 JP2013508289 A5 JP 2013508289A5 JP 2012534359 A JP2012534359 A JP 2012534359A JP 2012534359 A JP2012534359 A JP 2012534359A JP 2013508289 A5 JP2013508289 A5 JP 2013508289A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- nitrite
- composition according
- plasma concentration
- maintained
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US25148309P | 2009-10-14 | 2009-10-14 | |
| US61/251,483 | 2009-10-14 | ||
| PCT/US2010/052683 WO2011047161A1 (en) | 2009-10-14 | 2010-10-14 | Pharmaceutical formulations of nitrite and uses thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015113882A Division JP6125567B2 (ja) | 2009-10-14 | 2015-06-04 | ニトライトの医薬製剤及びそれらの使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013508289A JP2013508289A (ja) | 2013-03-07 |
| JP2013508289A5 true JP2013508289A5 (enExample) | 2013-10-31 |
| JP5758904B2 JP5758904B2 (ja) | 2015-08-05 |
Family
ID=43855036
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012534359A Expired - Fee Related JP5758904B2 (ja) | 2009-10-14 | 2010-10-14 | ニトライトの医薬製剤及びそれらの使用 |
| JP2015113882A Expired - Fee Related JP6125567B2 (ja) | 2009-10-14 | 2015-06-04 | ニトライトの医薬製剤及びそれらの使用 |
| JP2017074888A Pending JP2017141275A (ja) | 2009-10-14 | 2017-04-05 | ニトライトの医薬製剤及びそれらの使用 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015113882A Expired - Fee Related JP6125567B2 (ja) | 2009-10-14 | 2015-06-04 | ニトライトの医薬製剤及びそれらの使用 |
| JP2017074888A Pending JP2017141275A (ja) | 2009-10-14 | 2017-04-05 | ニトライトの医薬製剤及びそれらの使用 |
Country Status (10)
| Country | Link |
|---|---|
| US (4) | US10463689B2 (enExample) |
| EP (1) | EP2488035B1 (enExample) |
| JP (3) | JP5758904B2 (enExample) |
| CN (2) | CN107260756A (enExample) |
| AU (1) | AU2010306755B2 (enExample) |
| CA (1) | CA2777066C (enExample) |
| ES (1) | ES2633618T3 (enExample) |
| IL (1) | IL219155A0 (enExample) |
| IN (1) | IN2012DN03428A (enExample) |
| WO (1) | WO2011047161A1 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101939014B (zh) | 2007-11-15 | 2016-04-27 | 路易斯安那州大学及农业和机械学院管理委员会 | 亚硝酸盐在慢性缺血中的应用 |
| WO2010147742A2 (en) | 2009-06-18 | 2010-12-23 | Theravasc Inc. | Use of nitrite salts in treating tissue damage |
| CA2777066C (en) * | 2009-10-14 | 2020-02-18 | TheraVasc, LLC | Pharmaceutical formulations of nitrite and uses thereof |
| WO2013026000A1 (en) | 2011-08-17 | 2013-02-21 | Board Of Regents, The University Of Texas System | Method of producing physiological and therapeutic levels of nitric oxide through an oral delivery system |
| US8627204B2 (en) * | 2011-10-18 | 2014-01-07 | Microsoft Corporation | Custom optimization of web pages |
| ES2741146T3 (es) | 2013-02-20 | 2020-02-10 | The Board Of Supervisors Of The Louisiana State Univ Mechanical And Agricultural College | Formulaciones farmacéuticas de nitrio y sus usos |
| US20160081962A1 (en) * | 2013-05-10 | 2016-03-24 | Nitromega Corp. | Nutritional or dietary supplements containing fatty acids and nitrite |
| GB201309092D0 (en) | 2013-05-20 | 2013-07-03 | Edixomed Ltd | Transdermal delivery system |
| US20170349438A1 (en) | 2016-06-06 | 2017-12-07 | Theravasc Inc. | Pharmaceutical formulations of nitrite and uses thereof |
| CA3052206A1 (en) * | 2017-02-20 | 2018-08-23 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Hydrogen sulfide and/or nitrite in the treatment and prevention of atrial fibrillation |
| US11850271B1 (en) * | 2023-05-16 | 2023-12-26 | King Faisal University | Topical skin cream |
| WO2026006722A1 (en) | 2024-06-28 | 2026-01-02 | The Regents Of The University Of Michigan | Nitric oxide generating medical devices and methods |
Family Cites Families (45)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2914446A (en) * | 1958-06-26 | 1959-11-24 | Upjohn Co | Nitrite stabilized ascorbic acid-cyanocobalamin compositions |
| US4650484A (en) | 1983-02-03 | 1987-03-17 | Alza Corporation | Method for treating ischemic conditions |
| IE64726B1 (en) | 1987-11-20 | 1995-08-23 | Elan Corp Plc | Pharmaceutical formulations for preventing drug tolerance |
| US5122384A (en) | 1989-05-05 | 1992-06-16 | Kv Pharmaceutical Company | Oral once-per-day organic nitrate formulation which does not induce tolerance |
| US5278192A (en) | 1992-07-02 | 1994-01-11 | The Research Foundation Of State University Of New York | Method of vasodilator therapy for treating a patient with a condition |
| US6709681B2 (en) | 1995-02-17 | 2004-03-23 | Aberdeen University | Acidified nitrite as an antimicrobial agent |
| US20110196039A9 (en) * | 1994-10-05 | 2011-08-11 | Kaesemeyer Wayne H | Controlled release arginine formulations |
| US5648101A (en) | 1994-11-14 | 1997-07-15 | Tawashi; Rashad | Drug delivery of nitric oxide |
| US5770645A (en) | 1996-08-02 | 1998-06-23 | Duke University Medical Center | Polymers for delivering nitric oxide in vivo |
| US5994444A (en) * | 1997-10-16 | 1999-11-30 | Medtronic, Inc. | Polymeric material that releases nitric oxide |
| US7371415B1 (en) | 1998-04-03 | 2008-05-13 | The Daily Wellness Company | Method and composition for improving sexual fitness |
| US7015876B1 (en) * | 1998-06-03 | 2006-03-21 | Lear Corporation | Heads-up display with improved contrast |
| EP1105146A1 (en) | 1998-07-14 | 2001-06-13 | Paracelsian, Inc. | Method for identifying and confirming consistent bio-functionality of natural compositions |
| AU764469B2 (en) | 1999-01-29 | 2003-08-21 | Disphar International B.V. | Pharmaceutical compositions |
| GB9905425D0 (en) | 1999-03-09 | 1999-05-05 | Queen Mary & Westfield College | Pharmaceutical composition |
| US6314956B1 (en) | 1999-09-08 | 2001-11-13 | Duke University | Pulmonary delivery of NO group-containing compound in gas form to treat respiratory, cardiac and blood disorders |
| GB0119011D0 (en) * | 2001-08-03 | 2001-09-26 | Univ Aberdeen | Treatment of nail infections |
| EP1492509A1 (en) | 2001-12-18 | 2005-01-05 | ALZA Corporation | Dosage form providing time-varying patterns of drug delivery |
| EP1336602A1 (en) | 2002-02-13 | 2003-08-20 | Giovanni Scaramuzzino | Nitrate prodrugs able to release nitric oxide in a controlled and selective way and their use for prevention and treatment of inflammatory, ischemic and proliferative diseases |
| EP1495026A4 (en) * | 2002-03-20 | 2008-07-09 | Univ Queensland | METHOD AND COMPOSITIONS CONTAINING STAIN OXIDE DISPENSERS AND OPIOLD ANALGETICS |
| CA2379211A1 (fr) | 2002-03-28 | 2003-09-28 | Institut De Cardiologie De Montreal | Utilisation du bleu de methylene pour renverser la reaction hemodynamique exageree induite par la combinaison d'un derive nitre et du sildenafil ou d'une molecule de meme classe (inhibiteur de la phosphodiesterase) |
| JP5564157B2 (ja) | 2003-07-09 | 2014-07-30 | ザ ガバメント オブ ザ ユナイテッド ステイツ オブ アメリカ アズ リプレゼンテッド バイ ザ セクレタリー オブ ザ デパートメント オブ ヘルス アンド ヒューマン サービシーズ | 心臓血管状態の処置のための亜硝酸塩の使用方法 |
| EP1670459A4 (en) | 2003-08-20 | 2009-03-25 | Nitromed Inc | NITROSED AND NITROSYLATED CARDIOVASCULAR COMPOUNDS, COMPOSITIONS AND APPLICATION METHODS |
| WO2005023189A2 (en) | 2003-09-03 | 2005-03-17 | Pharmacia Corporation | Method of cox-2 selective inhibitor and nitric oxide-donating agent |
| US7362274B1 (en) | 2004-07-09 | 2008-04-22 | Huan-Cheng Lien | Coupled feed-in butterfly shaped left/right hand circularly polarized microstrip antenna |
| US20060083824A1 (en) | 2004-10-20 | 2006-04-20 | Pbm Products Llc | Nutritional supplements for glucose intolerant individuals |
| EP1846058B1 (en) * | 2005-02-11 | 2009-07-15 | NOLabs AB | Device method, and use for treatment of neuropathy involving nitric oxide |
| BRPI0610180A2 (pt) | 2005-05-24 | 2012-09-25 | Wellgen Inc | métodos para prevenir, para tratar, e para tratar ou controlar uma condição associada à inflamação |
| NZ594596A (en) * | 2006-02-10 | 2011-10-28 | Mannatech Inc | All natural multivitamin and multimineral dietary supplement formulations for enhanced absorption and biological utilization |
| GB0607402D0 (en) | 2006-04-12 | 2006-05-24 | Barts & London Nhs Trust | Therapeutic composition and use |
| WO2007149520A2 (en) | 2006-06-21 | 2007-12-27 | Albert Einstein College Of Medicine Of Yeshiva University | Compositions for sustained release of nitric oxide, methods of preparing same and uses thereof |
| JP2010519336A (ja) | 2007-02-26 | 2010-06-03 | ルンドベルク，ヨン | 亜硝酸塩及び硝酸塩及びこれらを含む組成物の新規使用 |
| PL2124638T3 (pl) | 2007-02-26 | 2017-07-31 | Heartbeet Ltd. | Kompozycja zwiększająca wydolność i jej zastosowanie |
| WO2008153762A2 (en) | 2007-05-25 | 2008-12-18 | N30 Pharmaceuticals, Llc | S-nitrosothiol formulations and storage systems |
| WO2009021058A2 (en) * | 2007-08-06 | 2009-02-12 | Trinity Labortories, Inc. | Pharmaceutical compositions for treating chronic pain and pain associated with neuropathy |
| CN101939014B (zh) | 2007-11-15 | 2016-04-27 | 路易斯安那州大学及农业和机械学院管理委员会 | 亚硝酸盐在慢性缺血中的应用 |
| US20090196930A1 (en) | 2007-12-27 | 2009-08-06 | Aires Pharmaceuticals, Inc. | Aerosolized nitrite and nitric oxide -donating compounds and uses thereof |
| WO2010036236A1 (en) | 2008-09-23 | 2010-04-01 | Baker Hughes Incorporated | Anchor assembly |
| US8568793B2 (en) * | 2009-02-11 | 2013-10-29 | Hope Medical Enterprises, Inc. | Sodium nitrite-containing pharmaceutical compositions |
| WO2010147742A2 (en) | 2009-06-18 | 2010-12-23 | Theravasc Inc. | Use of nitrite salts in treating tissue damage |
| US20130209584A1 (en) | 2009-10-14 | 2013-08-15 | Theravasc Inc. | Pharmaceutical formulations of nitrite and uses thereof |
| CA2777066C (en) * | 2009-10-14 | 2020-02-18 | TheraVasc, LLC | Pharmaceutical formulations of nitrite and uses thereof |
| WO2012135623A1 (en) | 2011-03-31 | 2012-10-04 | Theravasc Inc. | Use of nitrites for the treatment of cerebral amyloid angiopathy, age associated dementia, and cognitive decline |
| WO2012142413A2 (en) | 2011-04-14 | 2012-10-18 | Theravasc Inc. | Nitrite compositions and uses thereof |
| US9294956B2 (en) | 2011-12-29 | 2016-03-22 | Qualcomm Incorporated | Application-server-assisted preemptive multicast bearer establishment for real-time low-latency applications |
-
2010
- 2010-10-14 CA CA2777066A patent/CA2777066C/en active Active
- 2010-10-14 CN CN201710462544.3A patent/CN107260756A/zh active Pending
- 2010-10-14 IN IN3428DEN2012 patent/IN2012DN03428A/en unknown
- 2010-10-14 AU AU2010306755A patent/AU2010306755B2/en not_active Ceased
- 2010-10-14 ES ES10824097.9T patent/ES2633618T3/es active Active
- 2010-10-14 WO PCT/US2010/052683 patent/WO2011047161A1/en not_active Ceased
- 2010-10-14 JP JP2012534359A patent/JP5758904B2/ja not_active Expired - Fee Related
- 2010-10-14 US US12/904,791 patent/US10463689B2/en active Active
- 2010-10-14 CN CN2010800568984A patent/CN102686111A/zh active Pending
- 2010-10-14 EP EP10824097.9A patent/EP2488035B1/en active Active
-
2012
- 2012-04-15 IL IL219155A patent/IL219155A0/en unknown
-
2015
- 2015-06-04 JP JP2015113882A patent/JP6125567B2/ja not_active Expired - Fee Related
- 2015-09-08 US US14/847,966 patent/US10307441B2/en active Active
-
2017
- 2017-04-05 JP JP2017074888A patent/JP2017141275A/ja active Pending
-
2019
- 2019-10-11 US US16/599,710 patent/US20200085861A1/en not_active Abandoned
-
2020
- 2020-06-11 US US16/898,460 patent/US20200297756A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20250480T1 (hr) | Kombinacija dasatiniba i adagrasiba za primjenu u liječenju nesitnostaničnog raka pluća | |
| RU2012147739A (ru) | Пероральные составы, содержащие аналоги цитидина, и способы их использования | |
| WO2013101897A3 (en) | Improved compositions and methods for delivery of omeprazole plus acetylsalicylic acid | |
| JP2012502015A5 (enExample) | ||
| JP2012502047A5 (enExample) | ||
| HK1221646A1 (zh) | 高剂量普利多匹定用於治疗亨廷顿舞蹈症的用途 | |
| NZ625592A (en) | Compositions and methods for the treatment of hepatic diseases and disorders | |
| JP2012193216A5 (enExample) | ||
| JP2015038135A5 (enExample) | ||
| MX2011007779A (es) | Formulaciones galenicas de compuestos organicos. | |
| WO2011118976A3 (en) | Pharmaceutical composition for the prevention or the treatment of non-alcoholic fatty liver disease and the method for prevention or treatment of non-alcoholic fatty liver disease using the same | |
| RU2011152105A (ru) | Составы таблеток 3-цианохинолина и их применение | |
| WO2009034431A3 (en) | Controlled-release dosage forms for varenicline | |
| SI2760821T1 (en) | A salt salt of an anti-inflammatory substituted cyclobutenedione compound | |
| NZ587202A (en) | Methods for measuring a patient response upon administration of a drug and compositions thereof | |
| FI4212152T3 (fi) | Sakubitriili-valsartaaniannostusohjelma kroonisen systolisen sydämen vajaatoiminnan hoitoon | |
| JP2014503593A5 (enExample) | ||
| JP2009513713A5 (enExample) | ||
| WO2012020301A3 (en) | Oral controlled release pharmaceutical compositions of blonanserin | |
| NZ611026A (en) | Pharmaceutical composition comprising citrate and bicarbonate salts, and use thereof for treating cystinuria | |
| RU2018146504A (ru) | Лечение внутрипеченочных холестатических заболеваний | |
| WO2007145863A3 (en) | Sustained release formulation of naltrexone | |
| JP2016512247A5 (enExample) | ||
| JP2016505050A5 (enExample) | ||
| JP2008088189A5 (enExample) |